These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Quarterly Period Ended
September 30, 2015
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Transition Period From ________ to _________
|
|
Utah
|
87-0285238
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
1201 Dove Street, Suite 300
|
|
|
Newport Beach, California
|
92660
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
Non-accelerated filer (Do not check if a smaller reporting company)
o
|
Smaller reporting company
x
|
|
Page
|
||
|
PART I — FINANCIAL INFORMATION
|
||
|
3
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
8
|
||
|
20
|
||
|
20
|
||
|
PART II — OTHER INFORMATION
|
||
|
21
|
||
|
21
|
||
|
21
|
||
|
22
|
||
|
September 30,
2015
|
December 31, 2014
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash
|
$
|
3,281,140
|
$
|
2,946,025
|
||||
|
Accounts receivable, net of allowance of $67,260 and $40,510
|
1,508,168
|
1,868,181
|
||||||
|
Deferred tax asset
|
77,059
|
77,059
|
||||||
|
Prepaid income taxes
|
240,359
|
2,703
|
||||||
|
Prepaid expenses
|
88,178
|
77,278
|
||||||
|
Total current assets
|
5,194,904
|
4,971,246
|
||||||
|
Property and Equipment, net
|
||||||||
|
Computer equipment
|
294,405
|
222,240
|
||||||
|
Furniture and fixtures
|
149,541
|
92,191
|
||||||
|
Office equipment
|
27,160
|
27,160
|
||||||
|
Office equipment under capital lease
|
-
|
63,923
|
||||||
|
Total property and equipment
|
471,106
|
405,514
|
||||||
|
Less: accumulated depreciation and amortization
|
(245,472
|
)
|
(226,329
|
)
|
||||
|
Net property and equipment
|
225,634
|
179,185
|
||||||
|
Other Assets
|
26,788
|
8,158
|
||||||
|
Total assets
|
$
|
5,447,326
|
$
|
5,158,589
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
133,925
|
$
|
240,214
|
||||
|
Accrued expenses
|
282,477
|
261,510
|
||||||
|
Income tax payable
|
4,867
|
9,348
|
||||||
|
Current obligations under capital lease
|
-
|
8,151
|
||||||
|
Deferred rent expense
|
258
|
14,332
|
||||||
|
Dividend payable
|
133,420
|
-
|
||||||
|
Unearned revenue
|
40,904
|
-
|
||||||
|
Total current liabilities
|
595,851
|
533,555
|
||||||
|
Commitments and Contingencies
|
-
|
-
|
||||||
|
Shareholders’ Equity
|
||||||||
|
Preferred stock; 5,000,000 shares authorized at $0.001 par value;
zero shares issued and outstanding
|
-
|
-
|
||||||
|
Common stock, $0.001 par value 50,000,000 shares authorized at
September 30, 2015 and December 31, 2014; 802,424 shares issued,
(794,072 outstanding net of treasury shares) and 802,424 shares issued,
(800,396 outstanding net of treasury shares), respectively
|
794
|
800
|
||||||
|
Additional paid-in capital
|
623,637
|
623,631
|
||||||
|
Treasury stock at cost (8,269 shares and 2,028 shares at September 30, 2015 and
December 31, 2014), respectively
|
(254,057
|
) |
(76,715
|
)
|
||||
|
Retained earnings
|
4,481,101
|
4,077,318
|
||||||
|
Total stockholders’ equity
|
4,851,475
|
4,625,034
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
5,447,326
|
$
|
5,158,589
|
||||
|
For three months ended
September 30,
|
For nine months ended
September 30,
|
|||||||||||||||
|
2015
|
2014
|
2015
|
2014
|
|||||||||||||
|
Revenues:
|
||||||||||||||||
|
UR fees
|
$
|
1,027,893
|
$
|
1,362,283
|
$
|
3,004,023
|
$
|
3,063,833
|
||||||||
|
MBR fees
|
201,903
|
526,341
|
855,089
|
1,444,524
|
||||||||||||
|
HCO fees
|
273,089
|
260,069
|
920,789
|
778,869
|
||||||||||||
|
MPN fees
|
224,128
|
285,415
|
779,941
|
797,449
|
||||||||||||
|
NCM fees
|
216,216
|
242,376
|
695,755
|
753,839
|
||||||||||||
|
Other
|
126,352
|
76,032
|
444,187
|
240,882
|
||||||||||||
|
Total revenues
|
2,069,581
|
2,752,516
|
6,699,784
|
7,079,396
|
||||||||||||
|
Expenses:
|
||||||||||||||||
|
Depreciation and amortization
|
16,011
|
12,642
|
44,686
|
35,408
|
||||||||||||
|
Bad debt provision
|
9,750
|
15,851
|
26,677
|
24,991
|
||||||||||||
|
Consulting fees
|
90,063
|
76,790
|
268,588
|
229,010
|
||||||||||||
|
Salaries and wages
|
555,666
|
699,096
|
1,874,572
|
1,878,041
|
||||||||||||
|
Professional fees
|
99,418
|
109,871
|
315,357
|
338,403
|
||||||||||||
|
Insurance
|
83,283
|
82,155
|
256,265
|
225,035
|
||||||||||||
|
Outsource service fees
|
295,507
|
658,233
|
963,059
|
1,324,248
|
||||||||||||
|
Data maintenance
|
11,819
|
12,953
|
120,413
|
53,685
|
||||||||||||
|
General and administrative
|
139,035
|
133,449
|
436,644
|
396,156
|
||||||||||||
|
Total expenses
|
1,300,552
|
1,801,040
|
4,306,261
|
4,504,977
|
||||||||||||
|
Income from operations
|
769,029
|
951,476
|
2,393,523
|
2,574,419
|
||||||||||||
|
Other expense
|
||||||||||||||||
|
Interest expense
|
(6
|
) |
(258
|
) |
(201
|
)
|
(956
|
)
|
||||||||
|
Total other expense
|
(6
|
) |
(258
|
) |
(201
|
)
|
(956
|
)
|
||||||||
|
Income before taxes
|
769,023
|
951,218
|
2,393,322
|
2,573,463
|
||||||||||||
|
Income tax provision
|
319,992
|
395,803
|
996,949
|
1,070,822
|
||||||||||||
|
|
||||||||||||||||
|
Net income
|
$
|
449,031
|
$
|
555,415
|
$
|
1,396,373
|
$
|
1,502,641
|
||||||||
|
|
||||||||||||||||
|
Basic and fully diluted earnings per share:
|
||||||||||||||||
|
Earnings per share amount
|
$
|
.57
|
$
|
.69
|
$
|
1.76
|
$
|
1.87
|
||||||||
|
Weighted average common shares outstanding
|
794,072
|
802,424
|
794,072
|
802,424
|
||||||||||||
|
Nine months ended
September 30,
|
||||||||
|
2015
|
2014
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
1,396,373
|
$
|
1,502,641
|
||||
|
Adjustments to reconcile net income to net cash:
|
||||||||
|
Depreciation and amortization
|
44,686
|
35,408
|
||||||
|
Changes in operating assets and liabilities
|
||||||||
|
Increase (decrease) in bad debt provision
|
26,750
|
(327
|
)
|
|||||
|
Decrease (increase) in accounts receivable
|
333,263
|
|
(567,614
|
)
|
||||
|
(Increase) in other assets
|
(18,630
|
)
|
(5,544
|
)
|
||||
|
(Increase) decrease in prepaid income tax
|
(237,656
|
) |
6,568
|
|||||
|
(Increase) in prepaid expenses
|
(10,900
|
)
|
(6,703
|
)
|
||||
|
(Decrease) increase in accounts payable
|
(106,289
|
)
|
225,270
|
|||||
|
Increase in accrued expenses
|
20,967
|
56,170
|
||||||
|
(Decrease) increase in income tax payable
|
(4,481
|
)
|
153,121
|
|||||
|
(Decrease) in deferred rent expense
|
(14,074
|
)
|
(5,448
|
)
|
||||
|
Increase in unearned revenue
|
40,904
|
-
|
||||||
|
Net cash provided by operating activities
|
1,470,913
|
1,393,542
|
||||||
|
Cash flows used in investing activities
|
||||||||
|
Purchases of computers, furniture and equipment
|
(91,135
|
)
|
(69,855
|
)
|
||||
|
Net cash used by investing activities
|
(91,135
|
)
|
(69,855
|
)
|
||||
|
Cash flows used in financing activities
|
||||||||
|
Purchase of treasury stock
|
(177,342
|
)
|
-
|
|||||
|
Issuance of cash dividend
|
(859,170
|
)
|
-
|
|||||
|
Payment of obligation under capital lease
|
(8,151
|
)
|
(9,787
|
)
|
||||
|
Net cash used in financing activities
|
(1,044,663
|
)
|
(9,787
|
)
|
||||
|
Increase in cash
|
335,115
|
1,313,900
|
||||||
|
Cash at beginning of period
|
2,946,025
|
1,265,535
|
||||||
|
Cash at end of period
|
$
|
3,281,140
|
$
|
2,579,435
|
||||
|
Supplemental Cash Flow Information
|
||||||||
|
Cash paid for:
|
||||||||
|
Interest
|
$
|
205
|
$
|
959
|
||||
|
Income taxes paid
|
$
|
1,239,086
|
$
|
911,134
|
||||
|
Non-cash financing and investing activities:
|
||||||||
|
Dividend payable
|
$
|
133,420
|
$
|
-
|
||||
|
9/30/15
|
12/31/14
|
|||||||
|
Customer A
|
38
|
%
|
25
|
%
|
||||
|
Customer B
|
20
|
%
|
22
|
%
|
||||
|
|
·
|
Health Care Organizations (“HCOs”)
|
|
|
·
|
Medical Provider Networks (“MPNs”)
|
|
|
·
|
HCO + MPN
|
|
|
·
|
Workers’ Compensation Carve-Outs
|
|
|
·
|
Utilization Review (“UR”)
|
|
|
·
|
Medical Bill Review (“MBR”)
|
|
|
·
|
Nurse Case Management (“NCM”)
|
|
|
·
|
Lien Representation Services
|
|
For the nine months ended
September 30,
|
||||||||
|
2015
(unaudited)
|
2014
(unaudited)
|
|||||||
|
Net cash provided by operating activities
|
$
|
1,470,913
|
$
|
1,393,542
|
||||
|
Net cash used in investing activities
|
(91,135
|
)
|
(69,855
|
)
|
||||
|
Net cash used in financing activities
|
(1,044,663
|
)
|
(9,787
|
)
|
||||
|
Net increase in cash
|
$
|
335,115
|
$
|
1,313,900
|
||||
|
Payments Due By Period
|
||||||||||||||||||||
|
Total
|
Less than 1 year
|
1-3 years
|
3-5 years
|
More than 5 years
|
||||||||||||||||
|
Operating Leases:
|
||||||||||||||||||||
|
Operating Leases – Equipment (1)
|
$
|
22,122
|
$
|
18,415
|
$
|
3,707
|
$
|
-
|
$
|
-
|
||||||||||
|
Office Leases (2)
|
1,659,474
|
231,542
|
481,672
|
516,408
|
429,852
|
|||||||||||||||
|
Total Operating Leases
|
$
|
1,681,596
|
$
|
249,957
|
$
|
485,379
|
$
|
516,408
|
$
|
429,852
|
||||||||||
|
(1)
|
In October 2013 we entered into a 36 month operating lease for an office copy machine with monthly payments at $160.93. In December 2013 we leased two document scanners with monthly operating lease payments of $206.93 each for 36 months. In February 2014 we entered into a 36 month operating lease for an office copy machine with monthly payments at $960.
|
|
(2)
|
On July 23, 2015 we entered into a new 79 month lease (the “New Office Lease”) with our current landlord with the commencement date being September 28, 2015. Prior to July 23, 2015, we leased approximately 5,159 and 1,640 rentable square feet (the “Prior Premises”) located in suites 300 and 375, respectively, consisting of a total of 6,799 rentable square feet. The lease for the Prior Premises was terminated on September 28, 2015. Upon commencement of the New Lease, our lease obligation for suite 375 consisting of 1,640 rentable square feet terminated and is no longer in effect. To replace suite 375, we leased suite 350 consisting of 4,280 rentable square feet (the “Expansion Premises”). Under the terms of the New Office Lease, we now lease suite 300 and the Expansion Premises, for a total of 9,439 rentable square feet (the “Combined Premises”). The Combined Premises will serve as our principal executive offices, as well as, the principal offices of our operating subsidiaries, Medex, IRC, MLS, MMM and MMC.
|
|
|
(3)
|
In August 2012 we entered into a capital lease arrangement whereby we leased office server equipment for $38,380. The asset was recorded on our balance sheet under office equipment under capital lease and our liability incurred under the lease was recorded as current and noncurrent obligations under capital lease. The lease arrangement is for a term of 36 months at level rents with capital interest rate at 7.5%. The term of this capital lease arrangement expired in July 2015.
|
|
Rent Period
|
Annual Rent Payment
|
|||
|
Oct.1 to Dec. 31, 2015
|
$
|
55,277
|
||
|
Jan. 1 to Dec. 31, 2016
|
237,713
|
|||
|
Jan. 1 to Dec. 31, 2017
|
228,330
|
|||
|
Jan. 1 to Dec. 31, 2018
|
257,874
|
|||
|
Jan. 1 to Dec. 31, 2019
|
244,942
|
|||
|
Jan. 1 to Dec. 31, 2020
|
275,996
|
|||
|
Jan. 1 to Dec. 31, 2021
|
261,932
|
|||
|
Jan. 1 to Mar. 31, 2022
|
97.410
|
|||
|
Total
|
$
|
1,659,474
|
||
|
6/30/15
|
12/31/14
|
|||||||
|
Customer A
|
38
|
%
|
25
|
%
|
||||
|
Customer B
|
20
|
%
|
22
|
%
|
||||
|
For the months
|
Total number of shares purchased
|
Average price paid per share(1)
|
Total number of shares purchased as part of publicly announced plans or programs(2)
|
Maximum dollar value of shares that may yet be purchased under the plans or programs(3)
|
||||||||||||
|
July 1, 2015 to July 31, 2015
|
306
|
$
|
32.47
|
306
|
$
|
306,998
|
||||||||||
|
August 1, 2015 to August 31, 2015
|
2,810
|
$
|
20.75
|
2,810
|
$
|
246,943
|
||||||||||
|
September 1, 2015 to September 30, 2015
|
-
|
$
|
-
|
-
|
$
|
-
|
||||||||||
|
Total
|
3,116
|
$
|
21.90
|
3,116
|
$
|
-
|
||||||||||
|
(1)
|
Reflects executed price, exclusive of brokers’ commissions and fees.
|
|
(2)
|
On November 26, 2014, we announced that our board of directors adopted a share repurchase program (“Repurchase Program”) that commenced on December 1, 2014.
|
|
(3)
|
On September 1, 2015, based upon the recommendation of management, the board of directors of the Company terminated the Company’s Repurchase Program. Our stock Repurchase Program was scheduled to expire on November 30, 2015. Under the Repurchase Program the board of directors had allocated up to $500,000 for the repurchase of currently issued and outstanding common stock of the Company. As of September 30, 2015, we had repurchased 8,269 shares for approximately $254,057. Effective September 1, 2015, the board of directors of the Company approved the termination of the Repurchase Program.
|
|
Exhibit Number
|
Title of Document
|
|
|
Exhibit 31.1
|
||
|
Exhibit 31.2
|
||
|
Exhibit 32.1
|
||
|
Exhibit 101
|
The following materials from Pacific Health Care Organization, Inc.’s Quarterly Report on Form 10-Q for the period ended September 30, 2015 formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014, (ii) the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2015 and 2014, (iii) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2015 and 2014, and (iv) Notes to the Condensed Consolidated Financial Statements.
|
|
PACIFIC HEALTH CARE ORGANIZATION, INC.
|
|||
|
Date:
|
November 12, 2015
|
/s/ Tom Kubota
|
|
|
Tom Kubota
Chief Executive Officer
|
|||
|
Date:
|
November 12, 2015
|
/s/ Fred Odaka
|
|
|
Fred Odaka
Chief Financial Officer
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|